Andesa Financial Management’s Bristol-Myers Squibb BMY Stock Holding History

Andesa Financial Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$222K	Buy	+3,812	New	+$269K	0.11%	117
2022 Q4	–	Sell	-3,451	Closed	-$245K	–	143
2022 Q3	$245K	Buy	+3,451	New	+$250K	0.09%	133
2021 Q3	–	Sell	-60,821	Closed	-$4.06M	–	141
2021 Q2	$4.06M	Buy	60,821 +54,456	+856%	+$3.55M	1.22%	30
2021 Q1	$402K	Buy	+6,365	New	+$396K	0.13%	102

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Andesa Financial Management's BMY Position: Q1 2023 in Review

Andesa Financial Management opened a new position in Bristol-Myers Squibb (BMY) in Q1 2023: 3,812 shares worth $222K. The stake represents 0.11% of the portfolio and ranks #117 among its holdings. This is a return to the name: Andesa Financial Management previously reported a position in BMY as recently as Q3 2022.

Andesa Financial Management first reported a position in BMY in Q1 2021 and has held it in 4 quarters since. The position peaked at $4.06M in Q2 2021. 2,541 funds tracked by Wall St. Rank hold BMY as of Q1 2023.

Andesa Financial Management held 3,812 shares of Bristol-Myers Squibb worth $222K as of Q1 2023.
Bristol-Myers Squibb was a new Andesa Financial Management position in Q1 2023.
Bristol-Myers Squibb made up 0.11% of Andesa Financial Management's portfolio in Q1 2023, its #117 holding.
Andesa Financial Management first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 4 quarters since.
Andesa Financial Management's Bristol-Myers Squibb position peaked at $4.06M in Q2 2021.
2,541 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2023.

Based on Andesa Financial Management's 13F filing for Q1 2023, filed 5 May 2023.